You are viewing the site in preview mode

Skip to main content

Table 1 Clinical data of all patients in this study

From: Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer

Clinical data (n = 193)
Age (years), median (range) 57 (33–82)
Size (mm), median (range) 9 (2.5–15)
Pathology (IDC), n (%) 164 (85.0)
Lesion in right breast, n (%) 105 (54.4)
Duration between cryoablation and initial post-cryoablation PET/CT (months), median (range) 12 (2–36)
Radiation dose (Gy), median (range) 47.7 (39.6–60)
Boost to tumor bed, n (%) 42 (21.8)
Boost to tumor bed (Gy), median (range) 9 (2.5–12)
Duration between radiation and initial post-cryoablation PET/CT (months), median (range) 10 (3–33)
  1. IDC Invasive ductal carcinoma, PET/CT Positron emission tomography/computed tomography